PharmAla Announces Private Placement
13. Dezember 2024 09:25 ET
|
PharmAla Biotech
PharmAla announces private placement financing
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
09. Juni 2023 15:48 ET
|
PharmAla Biotech
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...